Badin Sindh Pakistan
Get Counselor
Epidemiology Quiz
Epidemiology quiz helps us to increase our knowledge
1 / 110
1.
2 / 110
2.
3 / 110
3.
4 / 110
4.
5 / 110
5.
6 / 110
6.
7 / 110
7.
8 / 110
8.
9 / 110
9.
10 / 110
10.
11 / 110
11. “Identify following situation by letters A, B, C, D, or E: Diagnosis that was established during the screening program Natural History of Disease Timeline: (Look at the Att # 1)”
12 / 110
12.
13 / 110
13.
14 / 110
14.
15 / 110
15.
16 / 110
16.
17 / 110
17.
18 / 110
18.
19 / 110
19.
20 / 110
20.
21 / 110
21.
22 / 110
22.
23 / 110
23.
24 / 110
24.
25 / 110
25.
26 / 110
26.
27 / 110
27.
28 / 110
28.
29 / 110
29.
30 / 110
30.
31 / 110
31.
32 / 110
32.
33 / 110
33.
34 / 110
34.
35 / 110
35. Information is presented correctly:
36 / 110
36.
37 / 110
37.
38 / 110
38.
39 / 110
39.
40 / 110
40.
41 / 110
41.
42 / 110
42.
43 / 110
43.
44 / 110
44.
45 / 110
45.
46 / 110
46.
47 / 110
47.
48 / 110
48.
49 / 110
49.
50 / 110
50.
51 / 110
51.
52 / 110
52.
53 / 110
53.
54 / 110
54.
55 / 110
55.
56 / 110
56.
57 / 110
57.
58 / 110
58.
59 / 110
59.
60 / 110
60.
61 / 110
61.
62 / 110
62.
63 / 110
63.
64 / 110
64.
65 / 110
65.
66 / 110
66.
67 / 110
67.
68 / 110
68.
69 / 110
69.
70 / 110
70.
71 / 110
71.
72 / 110
72.
73 / 110
73.
74 / 110
74.
75 / 110
75.
76 / 110
76.
77 / 110
77.
78 / 110
78.
79 / 110
79.
80 / 110
80.
81 / 110
81.
82 / 110
82.
83 / 110
83.
84 / 110
84.
85 / 110
85.
86 / 110
86.
87 / 110
87.
88 / 110
88.
89 / 110
89.
90 / 110
90.
91 / 110
91.
92 / 110
92.
93 / 110
93.
94 / 110
94.
95 / 110
95.
96 / 110
96.
97 / 110
97.
98 / 110
98.
99 / 110
99.
100 / 110
100.
101 / 110
101.
102 / 110
102.
103 / 110
103.
104 / 110
104.
105 / 110
105.
106 / 110
106.
107 / 110
107.
108 / 110
108.
109 / 110
109.
110 / 110
110.
Your score is
Restart quiz
1. Primary prevention
2. Secondary prevention
3. Tertiary prevention
4. Combination of primary and secondary
5. Combination of secondary and tertiary
2. Tertiary prevention
1. Tertiary prevention
2. Primary prevention
3. Secondary prevention
1. Sufficient
2. Necessary
3. Not necessary, not sufficient
4. It is not the cause
5. Both necessary and sufficient
2. Not necessary, not sufficient
3. It is not the cause
4. Necessary
1. Not necessary, not sufficient
2. Sufficient
3. Necessary
1. D
2. B
3. C
4. A
5. E
1. A
4. D
1. B
2. A
1. Determinants
2. Risk factor
3. Application
4. Distribution
5. Determinants and Application
2. Application
3. Risk factor
1. Ratio
2. Proportion
3. Rate
4. Ratio& Proportion
5. Proportion & Rate
1. Proportion
2. Rate
3. Ratio
1. Application
2. Determinants
3. Distribution
4. Risk factor
1. 7
2. 1
3. 4
4. 6
5. 3
1. 6
4. 3
5. 7
1. 4
3. 3
1. 3
1. 1000000/200*10
2. 1000-200*10
3. 200/1000000-100
4. 200*1000/10
5. 200/1000000
1. 450/10000-100
2. 10000-450*100
3. 450/10000*100
4. 450*10000/100
5. 10000/450*100
1. 468/1150*100
2. 1150/468
3. 468/1150-100
4. 1150/468*100
5. 1150-468/100
1. 100/25*100=400
2. 25/100=0.25
3. 100/25=4
4. 100-25=75
1. increase in incidence
2. decrease in prevalence
3. increase prevalence
4. decrease in incidence
1. All of the above
2. Causes
3. Sources
4. Risk factors
5. Agents
2. When
3. Where
4. Who
5. Agent, host, environment
1. 100/50000
2. 1500/50000
3. 5000/50000
4. 40/50000
1. 100/50000-5000
2. 40/50000
3. 1500/50000-1500
4. 5000/50000
1. (259 / 200) x 100
2. (200 + 259) / 100
3. 200 / 259 + 100
4. (200 / 259) x 100
1. The incidence of dysentery in the population of city N was 85.2 per 100 thousand population
2. The incidence of schoolchildren in city N in 1998 was 32.5 per 100 thousand population
3. The cumulative incidence of angina pectoris in persons older than 50 years in city N in 1998 was 18 per 100 population per year
4. The proportion of cases of arterial hypertension in men aged 20-55 years, on average in large cities of country N in 1990-98, was 25.3%
5. Prevalence of two types
1. 10-year age groups
2. Depends on the disease
3. 5-year age groups
4. 1-year age groups
5. Depends on the age
1. That the registered incidence rate is lower than the true
2. Prevalence of asymptomatic cases
3. Discrepancy of the registered morbidity and specific gravity of the persons having the corresponding antibodies
4. Slow-developing, hard-to-recognize infectious disease epidemics
5. All of the above
1. Interpretation of data
2. Monitoring programmes
3. Collection of data
4. Collection and interpretation of data
5. Improvement of research methods
1. Host
2. Study of endemic diseases
3. Environment
4. Agent
5. Time, place, person
1. It would increase prevalence of the disease
2. It would decrease mortality of the disease
3. It would decrease prevalence of the disease.
4. The effect on prevalence cannot be predicted from the information given.
5. It would have no effect on the prevalence of disease
2. The effect on prevalence cannot be predicted from the information given.
4. It would decrease mortality of the disease
1. Pandemic
2. Outbreak
3. Sporadic
4. Endemic
5. Epidemic
1. Lifetime prevalence
2. Incidence
3. Period prevalence
4. Mortality rate
5. Point prevalence
1. The emergence of new drugs that lead to an increase in the life expectancy of patients with disease X
2. Reducing the risk of new cases of disease X
3. Increasing death rate as a result of X-disease
4. The emergence of new drugs that increase the proportion of cured patients.
1. Epidemic
2. Endemic
4. Pandemic
5. Outbreak
1. Endemic
2. Sporadic
3. Epidemic
4. Outbreak
5. Pandemic
2. Epidemic
3. Pandemic
4. Sporadic
1. 4/16
2. 5/100
3. 10/11
4. 45/100
5. 46/184
1. 5/100
2. 10/11
3. 46/184
4. 4/16
5. 45/100
2. Resistance of the entire community because of the people immunity within the community
3. Immunity gained from a person to person transaction
4. The development of immunity from previous exposure to an agent before a vaccine or natural infection
5. Acquired immunity from previous exposure to an agent before a vaccine.
1. Foodborne
2. Direct contact
3. Vectorborne
4. Droplet spread
2. Droplet spread
3. Vehicleborne
4. Airborne
5. Vectorborne
2. 46/184
5. 5/100
1. 46/184
2. 45/100
4. 5/100
5. 4/16
1. The development of immunity from previous exposure to an agent before a vaccine or natural infection
2. Immunity gained from a person to person transaction
3. Acquired immunity from previous exposure to an agent before a vaccine.
4. Resistance of the entire community because of the people immunity within the community
5. Immunogenicity
1. Experimental
2. Observational cohort
3. Observational case-control
4. Observational cross-sectional
5. Not an analytical or epidemiologic study
1. Observational case-control
3. Experimental
5. Clinical trial
2. Observational case-control
3. Cohort
2. Observational
1. Reservoir
2. Vehicle
3. Vector
4. Carrier
5. Agent
1. 17/83 = 0.205
2. 1/99 = 0.09
3. 1/99 = 0.01
4. 0.205/0.01=20.5
5. 17/83 = 20.5
1. 1/99 = 0.01
2. 17/83 = 20.5
3. 17/83 = 0.205
4. 1/99 = 0.09
5. 17/100 = 0.017
1. Odds Ratio
2. Ecologic Correlation
3. Relative Risk
4. Indigence
5. Prevalence
1. Case-control
2. Cohort study
3. Randomized controlled trial
4. Cross-sectional
5. Ecological study
1. Cohort
2. Experimental
3. Cross-sectional
4. Case-control
1. It may be used to study etiology of a rare disease.
2. Multiple disease outcomes following a selected exposure can be readily studied.
3. Dependence on recall by subjects in the study minimized.
4. It is possible to determine the true incidence of the disease.
5. There is little or no bias in assessment of exposure
1. OR = (152 × 103)/ (17 × 248) = (15656/4216) = 3.71.
2. OR = (152 – 103)/ (17 – 248) = (15656/4216) = 3.71.
3. OR = (152 / 103)+ (17/ 248) = (15656/4216) = 3.71
4. OR = (152 × 103)+ (17 × 248) = (15656/4216) = 3.71.
5. OR = (152 + 103)/ (17 + 248) = (15656/4216) = 3.71.
1. OR = (a/b)/(c/d) = (152/17)/(262/103) = 8.94/2.41 = 3.71
2. OR = (a/b)-(c/d) = (152/17)/(262/103) = 8.94/2.41 = 3.71
3. OR = (a/b)/(c/d) = (152/17)/(262/103) = 8.94/2.41 = 3.
4. OR = (a/c)/(c/d) = (152/17)/(262/103) = 8.94/2.41 = 3.71
5. OR = (a/c)/(b/d) = (152/17)/(262/103) = 8.94/2.41 = 3.71
1. 0.2
2. 5.0
3. 10
4. 50
5. 0.1
1. 5.0
2. 0.2
1. 85*75/25*15
2. 85/15*25/75
3. (85/85+15)/(25/25+75)=
4. (85/85+25)/(15/15+75)=
5. 85*25/75*15
1. (60/60+40)/(25/25+75)=
2. B. (60/100+40)/(25/100+75)=
3. (60/60+25)/(40/40+75)=
4. (60*75)/(25*40)=
5. (60*40)/(25*75)=
1. (60*75)/(25*40)=
4. (60/60+40)/(25/25+75)=
1. Odds ratio
2. Relative risk
3. prevalence
4. Confidence interval
5. incidence
1. Experimental study
2. Case-control
3. Clinical trial
4. Cohort
1. Subjects are enrolled or categorized on the basis of their exposure status in a cohort study but not in a case-control study
2. Cohort studies are conducted to investigate chronic diseases, case-control studies are used for infectious diseases
3. Cohort studies require many years to conduct, but case-control studies do not
4. Subjects are asked about their exposure status in a cohort study but not in a casecontrol study
5. neither above
1. Rare diseases
2. Chronic disease
3. One consequence of different causes in one study
4. Different effects of one cause in one study
1. (85/85+15)/(25/25+75)=
2. (85/85+25)/(15/15+75)=
3. 85*25/75*17
4. 85*75/25*17
5. 85/15*25/77
1. (85/85+25)/(15/15+75)=
2. 85/15*25/76
4. 85*75/25*16
5. 85*25/75*16
2. Cross-Sectional
4. Ecological
5. Case-control
1. Statins
2. Stroke
3. CVD
4. Diabetes
5. Other disorders
1. Sign the "Informed consent of the patient" (where his consent to the use of placebo is provided)
2. The attending physician receives the patient's oral consent to conduct the experiment
3. Placebo has no harmful effects on the body, so its use does not require the consent of the patient
4. Sign consent for hospitalization
5. Sign consent for discharge
1. It is impossible for any type of study
2. Placebo-controlled
3. Double blind
4. Triple blind
5. Single blind
1. Randomization
2. Placebo
3. Supplement
4. Analog of the studied drug
5. Homeopathic medicine
1. Alcohol consumption
2. CVD
3. Association
4. Other disorders
5. Diabetes
2. Diabetes
4. Association
1. 6*46 / 4*44
2. 6/50 / 4/100
3. 6/6+4 / 44/44+46
4. 4*46 / 6*44
5. 50 / 4*44
1. A, B,C,D=6, 4, 50, 50
2. A, B,C,D=4, 6, 46, 44
3. A, B,C,D=4, 6, 50, 50
4. A, B,C,D=6, 4, 44, 46
5. A, B,C,D=6, 46, 44, 4
1. RR
2. Percentage
3. OR
4. Proportion
5. Attributable risk
1. AIDS
2. HIV
3. Antiretroviral therapy
4. Did not follow antiretroviral regimen
5. Followed antiretroviral regimen
1. 18*10 / 200*82
2. 18*98 / 2*82
3. 18/ 100
4. 18/ 2*82
5. 18/ 18+2 / 82/ 82+98
1. A, B,C,D= 18, 82, 2, 98
2. A, B,C,D= 18, 2, 20, 100
3. A, B,C,D= 5, 45, 5, 45
4. A, B,C,D= 98,8 2, 2, 18
5. A, B,C,D=18, 2, 82, 98
2. OR
3. Attributable risk
5. Percentage
2. Ecological
4. Cross-Sectional
5. Cohort
1. Secondary prevention
3. Combination of primary and secondary
4. Primary prevention
2. C
3. D